PRECIDENTD (PREvention of CardIovascular and DiabEtic kidNey disease in Type 2 Diabetes)
PREvention of CardIovascular and Diabetic Kidney Disease in Type 2 Diabetes (PRECIDENTD)
Sponsor: PCORI
Enrolling: Male and Female Patients
Study Length: 5 Years
Clinic Visits: 9
IRB Number: AAAU2891
U.S. Govt. ID: NCT05390892
Contact: Anabel Evans: 212-851-5492 /
Additional Study Information: In PRECIDENTD, we hope to learn which diabetes medications work best to reduce the risk of heart and kidney disease in people with type 2 diabetes. People with type 2 diabetes are twice as likely to have heart disease or a stroke compared to someone who does not have diabetes, and they are likely to have heart disease or stroke at a younger age. People with type 2 diabetes and heart disease, stroke, or other vascular (blood vessel) disease or who have high risk for these can participate in the study. If you enroll in PRECIDENTD, you will: Be prescribed a diabetes medication that reduces the risk of heart disease in addition to lowering blood glucose and weight. Attend annual visits in-person or via telemedicine and complete questionnaires every 6 months for up to 8 years. Share your health information to help answer one of the most pressing questions in how to take care of people with type 2 diabetes. Receive $500 per year.
Jacqueline Lonier, MD
Do You Qualify?
Have you been diagnosed with type 2 diabetes? Yes No
Are you between the ages of 40 and 80? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Anabel Evans